BLADDER FLAT UROTHELIAL CARCINOMA IN SITU

Clinical trials for BLADDER FLAT UROTHELIAL CARCINOMA IN SITU explained in plain language.

Never miss a new study

Get alerted when new BLADDER FLAT UROTHELIAL CARCINOMA IN SITU trials appear

Sign up with your email to follow new studies for BLADDER FLAT UROTHELIAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapy fights tough bladder cancer

Disease control Ongoing

This study is testing if adding an immunotherapy drug (pembrolizumab) to a standard chemotherapy (gemcitabine) can better control a specific type of early-stage bladder cancer. The cancer in these patients has not responded to the usual first-line treatment (BCG). The goal is to …

Matched conditions: BLADDER FLAT UROTHELIAL CARCINOMA IN SITU

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

BLADDER FLAT UROTHELIAL CARCINOMA IN SITU

Get alerted when new BLADDER FLAT UROTHELIAL CARCINOMA IN SITU trials appear

New combo therapy fights tough bladder cancer